Corrigendum: Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?

Corrigendum: Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?

Saved in:

Bibliographic Details
Main Authors:	Marcin Gabryel, Oliwia Zakerska-Banaszak, Karolina Ladziak, Katarzyna Anna Hubert, Alina Baturo, Joanna Suszynska-Zajczyk, Magdalena Hryhorowicz, Agnieszka Dobrowolska, Marzena Skrzypczak-Zielinska
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Immunology
Subjects:	CXCL8 gene inflammatory bowel disease (IBD) inflammation interleukin 8 genetic variants Crohn’s disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1599125/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is a rare CXCL8 gene variant a new possible cause or course factor of inflammatory bowel disease?
by: Marcin Gabryel, et al.
Published: (2025-03-01)

Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes
by: Georgia Fousteri, et al.
Published: (2025-07-01)

Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
by: Aseel F Khalaf, et al.
Published: (2020-03-01)

Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk
by: Rafał Watrowski, et al.
Published: (2025-01-01)

Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU
by: Xin Hu, et al.
Published: (2025-02-01)

CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer
by: Qinghong Hu, et al.
Published: (2025-07-01)

Predictive value of inflammatory regulators TGFb1 and CXCL8 in tumor tissue in colorectal cancer
by: I. A. Bogomolova, et al.
Published: (2023-04-01)

Clinical and Phenotypic Characteristics of Early-Onset Inflammatory Bowel Disease: A Five-Year Observational Study
by: Ivan S. Samolygo, et al.
Published: (2025-07-01)

The impact of diet on the inflammatory bowel disease course – a literature review
by: Agnieszka Nowotarska, et al.
Published: (2024-11-01)

Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
by: Ronaldo Paolo Panganiban, et al.
Published: (2025-01-01)

Megakaryocyte phenotyping in response to SARS-CoV-2 variants
by: Marcin A Sowa, et al.
Published: (2025-12-01)

Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
by: Seungchan An, et al.
Published: (2024-10-01)

REGULATION OF THE CXCL10 EXPRESSION AND INVESTIGATION OF THE RELATIONSHIPS OF THE CXCL10 DNA SEQUENCE VARIATION AND DISEASE
by: Hayriye Şentürk Çiftçi, et al.
Published: (2023-02-01)

Sarcopenia in IBD patients and the role of nutritional and physical activity interventions in its management – a systematic review
by: Michalina Jurkiewicz, et al.
Published: (2025-02-01)

Targeting p-FGFR1<sup>Y654</sup> Enhances CD8+ T Cells Infiltration and Overcomes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma by Regulating the CXCL8–CXCR2 Axis
by: Hong Luo, et al.
Published: (2025-07-01)

SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil Extracellular Trap Formation via the NFATc1/CXCL8 Axis
by: Jian Gao, et al.
Published: (2024-11-01)

Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with Ulcerative Colitis and Crohn’s disease
by: Ankit V. Jain, et al.
Published: (2025-06-01)

Single-cell analysis reveals significant transcriptomic alterations in preclinical Crohn’s disease
by: Dimitrios Kioroglou, et al.
Published: (2025-05-01)

Bioinformatics analysis identifies NT5M modulates immune evasion through PD-L1 via CXCL8 in pancreatic adenocarcinoma
by: Chaojie Zhai, et al.
Published: (2025-07-01)

Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohort
by: Shiva T. Radhakrishnan, et al.
Published: (2025-12-01)

Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
by: Devadarssen Murdamoothoo, et al.
Published: (2021-05-01)

Relationship Between Patient Demographics and Biologic Therapy Use in Inflammatory Bowel Disease. A Single Center Cross‐Sectional Study
by: Mohammad Shehab, et al.
Published: (2025-01-01)

Modern Strategies in the Pharmacotherapy of Inflammatory Bowel Diseases – A Literature Review
by: Bartłomiej Czarnecki, et al.
Published: (2025-07-01)

New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01)

Early onset inflammatory bowel disease: manifestations, genetics and diagnosis
by: Bobak Moazzami, et al.
Published: (2019-10-01)

The E3 ubiquitin ligase MARCH2 controls TNF-α mediated inflammation by autoubiquitination
by: Kiramage Chathuranga, et al.
Published: (2025-05-01)

Atypical «overlapping» variants of inflammatory bowel diseases
by: Kh. M. Akhrieva, et al.
Published: (2024-10-01)

Characterization of the salivary microbiome of adults with inflammatory bowel disease
by: Vanessa DeClercq, et al.
Published: (2025-12-01)

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management
by: Kyeong-Ryoon Lee, et al.
Published: (2024-11-01)

A bibliometric analysis of inflammatory bowel disease research in the Arab world
by: Shadan AlMuhaidib, et al.
Published: (2025-05-01)

Treatment of refractory ulcers of the rectum by autologous stem-cell transplantation
by: S. F. Bagnenko, et al.
Published: (2024-11-01)

Unmet health-related needs in patients with Crohn’s disease in Belgium: a mixed-methods study
by: Claudia Schönborn, et al.
Published: (2025-06-01)

A ROLE FOR INTERLEUKIN 8 IN DIRECT REGULATION OF T CELL FUNCTIONAL ACTIVITY
by: M. E. Meniailo, et al.
Published: (2017-10-01)

Relationship of visfatin with obesity and osteoporosis in patients with inflammatory bowel disease: a narrative review
by: Alicja Ewa Ratajczak-Pawłowska, et al.
Published: (2025-03-01)

The Significance of Serum and Fecal Levels of Interleukin-6 and Interleukin-8 in Hospitalized Children with Acute Rotavirus and Norovirus Gastroenteritis
by: Shan-Ming Chen, et al.
Published: (2014-04-01)

The Absence of CXCL10 Activity Does Not Affect the Capability of CD8<sup>+</sup> T Cells to Migrate and Eliminate the Tissue Cysts of <i>Toxoplasma gondii</i> from the Brains of Chronically Infected Mice
by: Rajesh Mani, et al.
Published: (2024-10-01)

Castleman disease (literature review)
by: A. L. Melikyan, et al.
Published: (2016-08-01)

Evaluation of 8-Hydroxy-2'-Deoxyguanosine, Interleukin-8 and Malondialdehyde Among Patients with Cardiovascular Diseases in Ibadan, Oyo State.
by: Moronkeji A.I.*1, Olaniyan M.F.1
Published: (2024-07-01)

Activation of mechanosensitive ion channel Piezo1 linking metabolic reprogramming and pro-inflammatory responses in hepatocellular carcinoma
by: Juanfen Mo, et al.
Published: (2025-06-01)

Inflammatory bowel disease is associated with greater odds of complications following posterior lumbar fusion and further amplified for patients exposed to monoclonal antibody biologics
by: Anthony E. Seddio, BS, et al.
Published: (2024-12-01)